The Effect of Midazolam Premedication on Copeptine Concentration in Blood

See also
Status	Clinical Trial	Phase
Completed	`NCT03052660` - Impact of Preoperative Midazolam on Outcome of Elderly Patients	Phase 4
Completed	`NCT03931057` - The Use of ADV6209 for Premedication in Pediatric Anesthesia	Phase 4
Recruiting	`NCT01937611` - Intramuscular Dexmedetomidine as Premedication	Phase 4
Recruiting	`NCT04273035` - Handheld-multimedia Versus Oral Midazolam in Pediatric on Perioperative Anxiety	Phase 4

See also

Status

Clinical Trial

Phase

Completed

NCT03052660 - Impact of Preoperative Midazolam on Outcome of Elderly Patients

Phase 4

Completed

NCT03931057 - The Use of ADV6209 for Premedication in Pediatric Anesthesia

Phase 4

Recruiting

NCT01937611 - Intramuscular Dexmedetomidine as Premedication

Phase 4

Recruiting

NCT04273035 - Handheld-multimedia Versus Oral Midazolam in Pediatric on Perioperative Anxiety

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03474939
Study type	Interventional
Source	Medical University of Warsaw
Contact
Status	Completed
Phase	Phase 4
Start date	April 3, 2017
Completion date	March 1, 2019

The Effect of Midazolam Premedication on Copeptine Concentration in Blood

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms